Skip to main content
Clinical Trials/NCT04747171
NCT04747171
Unknown
Not Applicable

A Comparative Study of Postoperative Analgesia of Different Intrathecal Additives for Spinal Anaesthesia in Elective Caesarean Sections

Benha University0 sites105 target enrollmentApril 2021

Overview

Phase
Not Applicable
Intervention
intrathecal Magnesium
Conditions
Pain, Postoperative
Sponsor
Benha University
Enrollment
105
Primary Endpoint
analgesic effect
Last Updated
5 years ago

Overview

Brief Summary

we designed this randomized, single -blind, prospective clinical study to test postoperative analgesia of three intrathecal additives in elective caesarean sections which are magnesium, dexamethasone and dexmedetomidine.

Registry
clinicaltrials.gov
Start Date
April 2021
End Date
July 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Baher Said Elshahat Mohamed Abdelhady

Principal Investigator

Benha University

Eligibility Criteria

Inclusion Criteria

  • American Society of Anesthesiologists classII-III adult female patient (age :18 -40 years old )
  • Elective cesarean section under spinal anaesthesia
  • Gestational age \> 37 weeks
  • BMI less than 30 kg/m2

Exclusion Criteria

  • Patient refusal
  • unable to give consent
  • age \< 18 or \> 40
  • BMI more than 30 kg/m2
  • known allergy to the study medication
  • coagulopathies or on anticoagulant medications
  • diabetic neuropathy
  • patients with psychiatric disorders

Arms & Interventions

magnesium intrathecal

Intervention: intrathecal Magnesium

dexamethasone intrathecal

Intervention: intrathecal dexamthasone

dexmedetomidine intrathecal

Intervention: intrathecal dexmedetomidine

Outcomes

Primary Outcomes

analgesic effect

Time Frame: Up to 24 hours after surgery

duration of sensory block

Similar Trials